Skip to content
Trial Eligibility
Menu

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

NCT05889546

This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Small Cell Lung Cancer

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Indiana University
Last updated on ClinicalTrials.gov
July 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Indiana · 3

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center · Indianapolis, IN
  • Roudebush VA Medical Center · Indianapolis, IN
  • Sidney and Lois Eskenazi Hospital · Indianapolis, IN

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.